These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

969 related items for PubMed ID: 17786271

  • 1. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R, Gan YY, Yee KK, Soo KC, Olivo M.
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [Abstract] [Full Text] [Related]

  • 2. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
    Yee KK, Soo KC, Olivo M.
    Int J Mol Med; 2005 Dec; 16(6):993-1002. PubMed ID: 16273277
    [Abstract] [Full Text] [Related]

  • 3. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins.
    Bhuvaneswari R, Yuen GY, Chee SK, Olivo M.
    Photochem Photobiol Sci; 2007 Dec; 6(12):1275-83. PubMed ID: 18046482
    [Abstract] [Full Text] [Related]

  • 4. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY, Bay BH, Olivo M.
    Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I, Kamuhabwa AR, D'Hallewin MA, Baert L, De Witte PA.
    Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
    [Abstract] [Full Text] [Related]

  • 11. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K, Usuda J, Ichinose S, Ishizumi T, Hirata T, Inoue T, Maehara S, Imai K, Kubota M, Tsunoda Y, Yamada M, Tsutsui H, Yamada K, Kuroiwa Y, Furukawa K, Okunaka T, Kato H.
    Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
    [Abstract] [Full Text] [Related]

  • 12. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.
    Solban N, Selbo PK, Sinha AK, Chang SK, Hasan T.
    Cancer Res; 2006 Jun 01; 66(11):5633-40. PubMed ID: 16740700
    [Abstract] [Full Text] [Related]

  • 13. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
    Bhuvaneswari R, Yuen GY, Chee SK, Olivo M.
    Lasers Surg Med; 2011 Sep 01; 43(7):651-62. PubMed ID: 22057493
    [Abstract] [Full Text] [Related]

  • 14. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
    Tirand L, Frochot C, Vanderesse R, Thomas N, Trinquet E, Pinel S, Viriot ML, Guillemin F, Barberi-Heyob M.
    J Control Release; 2006 Mar 10; 111(1-2):153-64. PubMed ID: 16423422
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A, Fisher AM, Rucker N, Gomer CJ.
    Cancer Res; 2005 Oct 15; 65(20):9473-8. PubMed ID: 16230411
    [Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B, Zupkó I, de Witte PA.
    Int J Oncol; 2001 Apr 15; 18(4):737-42. PubMed ID: 11251168
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
    Chin W, Lau W, Cheng C, Olivo M.
    Int J Oncol; 2004 Sep 15; 25(3):623-9. PubMed ID: 15289863
    [Abstract] [Full Text] [Related]

  • 18. Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin.
    Du HY, Li Y, Olivo M, Yip GW, Bay BH.
    Oncol Rep; 2006 Dec 15; 16(6):1397-402. PubMed ID: 17089067
    [Abstract] [Full Text] [Related]

  • 19. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer.
    Du H, Bay BH, Mahendran R, Olivo M.
    Cancer Lett; 2006 Apr 28; 235(2):202-8. PubMed ID: 15935550
    [Abstract] [Full Text] [Related]

  • 20. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
    Kamuhabwa AA, Huygens A, De Witte PA.
    Int J Oncol; 2003 Nov 28; 23(5):1445-50. PubMed ID: 14532989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.